The most recent plenary meeting of the Observatory was held on 25 September in Geneva, hosted by the European Organization for Nuclear Research, known as CERN. Since 2013, the Observatory is run by The Euroeducationary Union for Atomic Agency and its meetings are co-chaired by the Nuclear Medicine Europe (NMEU).

The meeting provided an opportunity to hear about CERN’s role in radioisotope mass separation, as well as about the PRISMAP EC project, managed by CERN, which provides a wide range of radionuclides for medical research. The Observatory reviewed the global research reactor scheduling for the remainder of 2024 and 2025. DG ENER provided an update on the latest developments related to the creation of a European Radioisotope Valley initiative in the context of the SAMIRA action plan. 

The European Medicines Agency presented its ongoing initiatives to secure supply of medicines in the EU and to prevent shortages of medicinal products. DGs RTD, JRC and GROW, as well as REA, also presented their activities related to medical radioisotopes and SAMIRA.

The meeting also heard presentations from three French facilities: the Institut Laue–Langevin (ILL) research reactor, the Jules Horowitz Reactor (JHR) which is currently under construction and the Orano Stable Isotopes facility. NMEU, the European Association of Nuclear Medicine (EANM) and the OECD Nuclear Energy Agency (NEA) also presented their activities, including the upcoming Workshop on Medical Radioisotopes Supply planned on 24-25 October in Paris.

Following the meeting, a technical visit to the two CERN facilities ISOLDE and MEDICIS was held.